Advertisement

Topics

Companies Related to "Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer" [Most Relevant Company Matches] RSS

16:34 EDT 20th August 2018 | BioPortfolio

Here are the most relevant search results for "Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Screening Study Surgery Levels Participants Increased Genetic Risk" Companies 1–25 of 3,400+

Relevant

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes support for physicians, as well as genetic counseling as part of every order. Color’s goal is to expand physician-supported access to genetic information for breast and ovarian ...


South Asian Heart Center

The South Asian Heart Center, the first major non-profit devoted to combating the growing epidemic of heart disease among people from Bangladesh, India, Pakistan, Nepal, and Sri Lanka, has developed a unique preventative program. Offered at a minimal, subsidized cost, the Center assesses the risk for heart disease using an advanced screening process that k...

Population Genetics

Harnessing The Power of Populations™ Population Genetics’ approach takes the process of genetic analysis one step further. It enables the elaboration and testing of distinct hypotheses focused on both contiguous and non-contiguous regions of the genome. Whether these have been identified by other technologies such as investigation of gene expression levels, copy number variation, p...


GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...

Ameritox

The single-group, multi-dose study examined the ability of the Rx Guardian(SM) algorithm to differentiate among low, medium and high daily doses of OxyContin®. Oxycodone levels were detected in the urine of 36 healthy volunteers using a liquid chromatography-mass spectrometry (LC-MS-MS) assay. Participants were randomized to receive 80mg, 160mg or 240mg of daily OxyContin® to steady state cond...

diaDexus, Inc.

Founded in 1997 by SmithKline Beecham (now GlaxoSmithKline) and Incyte, diaDexus, Inc. is a privately held biotechnology company focused on discovering, developing, and commercializing novel, patent-protected diagnostic products with high clinical value.In June 2005, the FDA cleared the PLAC test as the first blood test for determining the risk for ischemic stroke associated with atherosclerosis. ...

Genetic Analysis

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the bacteria in the digestive system. The company markets the GA-map™ technology to three market segments: commercial routine testing, pharma companies and the research market. Genetic Analysis ...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intell...

Roskilde University

Roskilde University is a state university founded in 1972 with the objective of providing research and education at the highest level in the fields of natural science, social science and the humanities. These activities at Roskilde University are organised in ten departments; degrees are offered in a wide range of subjects at Bachelor, Master and Ph.D. levels.Many study programmes are now being of...

WaveTec Vision

WaveTec Vision, a privately held company, is the leader in wavefront-guided custom cataract™ surgery. Their breakthrough intraoperative aberrometer system ORange® is the first to be FDA registered for cataract surgery, offering patients increased accuracy and improved refractive outcomes. For more information on WaveTec and ORange, visit www.wavete...

CENTOGENE

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical...

22nd Century Group, Inc.

Founded in 1998, 22nd Century Limited, LLC (22nd Century) is a plant biotechnology company whose proprietary technology allows for the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased through genetic engineering and breeding. The company owns or exclusively controls 98 issued patents in 79 countries where ...

Northwest Weight Loss Surgery

Northwest Weight Loss Surgery,We understand that once you choose to have weight loss surgery, you want the best possible Lap Band surgeon.We are honored to have been selected by more patients than just about any other practice in the country.We do Lap Band surgery,We have been surgeons for a long time – but because we believe so strongly that weight loss surgery can have a tremendous impact...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

National Breast Center

National Breast Center located in Alexandria, VA is founded by David Weintritt MD, a board certified breast surgeon. The National Breast Center provides a comprehensive program for early detection, diagnosis, and treatment of breast cancer, as well as services for those at high risk for breast cancer. The Breast Center combines advanced technology and over...

European Randomized Study of Screening for Prostate Cancer (ERSPC)

ERSPC (European Randomized Study of Screening for Prostate Cancer)

Orange Tree Employment Screening

Founded in 1990, Orange Tree Employment Services provides employment screening, background screening and drug testing services to more than 2,000 companies. Orange Tree specializes in providing its clients with the proper risk management, information integration, efficiency analysis, and security tools to make informed decisions. Orange Tree is the only sc...

ImmunoMolecular Therapeutics

IM Therapeutics is developing personalized immuno-therapeutic drugs for autoimmune diseases based on the genetic risk attributed by human leukocyte antigen genes. The lead candidate drug is an oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. Our goal is to preserve pancreatic beta cell fun...

BioTime Incorporated

BioTime, Inc. (OTCBB: BTIM), based in Emeryville, California, is engaged in the research and development of aqueous-based synthetic solutions that may be used as plasma expanders, organ preservation solutions, or solutions to replace blood volume during low temperature surgery. These products are intended for several important medical applications including: the treatment of hypovolemia caused ...

Genetic Technologies Limited

Genetic Technologies was an early pioneer in recognizing important new applications for “non-coding” DNA (Deoxyribonucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all spec...

Image Guided Surgery Associates

Image Guided Surgery Associates, PC (IGSA) is a private medical practice specializing in Interventional Radiology/Image Guided Surgery. Interventional Radiology (IR) procedures are a major advancement in medicine because they involve less risk than open surgery, with less pain and a shorter recovery time. IGSA was founded in 2002 by Robert L. Worthington-Kirsch, MD, FSCVIR in order to deliver the ...

Health Risk Partners

Health Risk Partners (HRP), the Revenue Integrity Division of Verisk Health, is a leading healthcare technology firm and provider of risk adjustment services. The HRP team has extensive experience working with federal and state healthcare payment methodologies and transforming them into solid business practices for Medicare and Medicaid health plans. HRP i...

VisionGate, Inc.

VisionGate, Inc. is led by Dr. Alan Nelson, physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. VisionGate offers the first automated 3D cell imaging platform, the Cell-CT, which computes high-resolution 3D biosignatures f...

Natera, Inc.

Natera is a genetic testing company that has developed a proprietary bioinformatics technology (Parental Support) to deliver accurate and comprehensive high throughput testing for reproductive indications from tiny quantities of DNA – as small as that from a single cell. Natera operates a CLIA laboratory in Redwood City, Calif., providing a host of pr...


More From BioPortfolio on "Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks